SEC Form 4 · accession 0001628280-26-047396
AbCellera Biologics Inc. · ABCL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Victor Sandor
Director
Period of report
Jul 1, 2026
Accepted (ET)
Jul 6, 2026 · 6:04 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001703057
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share option (right to buy)F1 | $7.85 | Jul 1, 2026 | A | 152,207 | A | — | Jul 1, 2036 | Common Shares | 152,207 | 152,207 | D |
Explanation of responses
- F1The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on July 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.